mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
3e-11 |
mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
2e-10 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
5e-10 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
6e-10 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.32 |
9e-10 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-09 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
1e-09 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
5e-09 |
mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
7e-09 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-08 |